BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 32211442)

  • 1. The Toll-Like Receptor 3 Agonist Polyriboinosinic Polyribocytidylic Acid Increases the Numbers of NK Cells with Distinct Phenotype in the Liver of B6 Mice.
    Salem ML; El-Naggar SA; Mobasher MA; Elgharabawy RM
    J Immunol Res; 2020; 2020():2489407. PubMed ID: 32211442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of dendritic cells in the mouse liver: identification and characterization of four distinct populations.
    Lian ZX; Okada T; He XS; Kita H; Liu YJ; Ansari AA; Kikuchi K; Ikehara S; Gershwin ME
    J Immunol; 2003 Mar; 170(5):2323-30. PubMed ID: 12594254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and function of murine B220+CD11c+NK1.1+ cells identify them as a subset of NK cells.
    Blasius AL; Barchet W; Cella M; Colonna M
    J Exp Med; 2007 Oct; 204(11):2561-8. PubMed ID: 17923504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of macrophage colony-stimulating factor mobilized both CD11b+CD11c+ cells and NK1.1+ cells into peripheral blood.
    Misawa E; Sakurai T; Yamada M; Tamura Y; Motoyoshi K
    Int Immunopharmacol; 2004 Jun; 4(6):791-803. PubMed ID: 15135320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A population of CD62Llow Nk1.1- CD4+ T cells that resembles NK1.1+ CD4+ T cells.
    Chen H; Paul WE
    Eur J Immunol; 1998 Oct; 28(10):3172-82. PubMed ID: 9808186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of intrahepatic CD8+ T cell trapping and NK1.1+ cells in liver-mediated immune regulation.
    Shibolet O; Alper R; Zolotarov L; Trop S; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Clin Immunol; 2004 Apr; 111(1):82-92. PubMed ID: 15093555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The adjuvant effects of the toll-like receptor 3 ligand polyinosinic-cytidylic acid poly (I:C) on antigen-specific CD8+ T cell responses are partially dependent on NK cells with the induction of a beneficial cytokine milieu.
    Salem ML; El-Naggar SA; Kadima A; Gillanders WE; Cole DJ
    Vaccine; 2006 Jun; 24(24):5119-32. PubMed ID: 16704888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine endometrial and decidual NK1.1+ natural killer cells display a B220+CD11c+ cell surface phenotype.
    Mallidi TV; Craig LE; Schloemann SR; Riley JK
    Biol Reprod; 2009 Aug; 81(2):310-8. PubMed ID: 19369645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Participation of NK1.1+ T cells in the rejection of lpr alphabetaT cells when bone marrow cells of lpr mice are transplanted into B6 mice.
    Tsukahara A; Kawamura H; Iiai T; Moroda T; Suzuki S; Tada T; Minagawa M; Musha N; Hatakeyama K; Abo T
    Microbiol Immunol; 1998; 42(6):447-56. PubMed ID: 9688079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of mouse liver natural killer cells and NK1.1(+) T cells by bacterial superantigen-primed Kupffer cells.
    Dobashi H; Seki S; Habu Y; Ohkawa T; Takeshita S; Hiraide H; Sekine I
    Hepatology; 1999 Aug; 30(2):430-6. PubMed ID: 10421651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD11cloB220+ interferon-producing killer dendritic cells are activated natural killer cells.
    Vosshenrich CA; Lesjean-Pottier S; Hasan M; Richard-Le Goff O; Corcuff E; Mandelboim O; Di Santo JP
    J Exp Med; 2007 Oct; 204(11):2569-78. PubMed ID: 17923507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to malarial infection is achieved by the cooperation of NK1.1(+) and NK1.1(-) subsets of intermediate TCR cells which are constituents of innate immunity.
    Mannoor MK; Weerasinghe A; Halder RC; Reza S; Morshed M; Ariyasinghe A; Watanabe H; Sekikawa H; Abo T
    Cell Immunol; 2001 Aug; 211(2):96-104. PubMed ID: 11591113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of LY49 NK cell subsets in the regulation of murine cytomegalovirus infections.
    Tay CH; Yu LY; Kumar V; Mason L; Ortaldo JR; Welsh RM
    J Immunol; 1999 Jan; 162(2):718-26. PubMed ID: 9916691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct contributions of CD4+ T cell subsets in hepatic ischemia/reperfusion injury.
    Kuboki S; Sakai N; Tschöp J; Edwards MJ; Lentsch AB; Caldwell CC
    Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1054-9. PubMed ID: 19264952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
    Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
    J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-stranded RNA promotes CTL-independent tumor cytolysis mediated by CD11b
    Shime H; Matsumoto M; Seya T
    Cell Death Differ; 2017 Mar; 24(3):385-396. PubMed ID: 27834952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo acute depletion of CD8(+) T cells before murine cytomegalovirus infection upregulated innate antiviral activity of natural killer cells.
    Salem ML; Hossain MS
    Int J Immunopharmacol; 2000 Sep; 22(9):707-18. PubMed ID: 10884591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer cell depletion fails to influence initial CD4 T cell commitment in vivo in exogenous antigen-stimulated cytokine and antibody responses.
    Wang M; Ellison CA; Gartner JG; HayGlass KT
    J Immunol; 1998 Feb; 160(3):1098-105. PubMed ID: 9570522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by alpha-galactosylceramide in mice.
    Nakagawa R; Nagafune I; Tazunoki Y; Ehara H; Tomura H; Iijima R; Motoki K; Kamishohara M; Seki S
    J Immunol; 2001 Jun; 166(11):6578-84. PubMed ID: 11359810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired function of hepatic natural killer cells from murine chronic HBsAg carriers.
    Chen Y; Wei H; Sun R; Tian Z
    Int Immunopharmacol; 2005 Dec; 5(13-14):1839-52. PubMed ID: 16275620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.